Sabate, Arlene F.
HRN: 24-46-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2024
CEFTAZIDIME 1GM (VIAL)
01/26/2024
03/01/2024
IV
1 Gram
Q8hrs
DM Foot, Left
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes